Duke Cancer care is in Wake County
Headline Duke Cancer care is in Wake County Teaser Duke Cancer care locations in Cary and Raleigh provide Wake County residents and beyond more treatment options and greater access to the full scope of Duke Health’s cancer services and expertise. That means more access to clinical trials, studies, treatment regimens and targeted radiation therapy. More access to the top ranked doctors, researchers and specialists of Duke—all closer to home. Video Duke Health Expands Cancer Care Options in Wake County Teaser Header Comprehensive, compassionate cancer treatment has never been more convenient. Footer Heading Learn more about cancer care at Duke Footer Button Text Learn more Static Campaign True Location Heading Explore our Wake County locations. Static Location Duke Cancer Center Cary Duke Cancer Center Macon Pond Duke Cancer Center Raleigh Campaign Alias wakecountycancer
Breast cancer is the most common cancer among women in many countries, accounting for 1 in 4 newly diagnosed cancers . Moreover, it is the leading cause of cancer deaths in women in over 100 countries. As an integral part of the curative treatment for patients with breast cancer, the clinical utilization of radiation therapy (RT) has increased in recent decades. Thus, in this era of three-dimensional conformal and intensity-modulated RT, precise delineation of the clinical target volume (CTV) and the organ at risk (OAR) has become vital.
Pulsed low-dose rate radiation therapy has been shown to reduce normal tissue damage while decreasing DNA damage repair in tumor cells. In a cohort of patients treated with palliative or definitive pelvic reirradiation using pulsed low-dose rate radiation therapy, we observed substantial local control and low rates of toxicity.
Conclusions: Radiation therapy with concurrent 5-fluorouracil and mitomycin C chemotherapy is reasonably well-tolerated as curative treatment for HIV+ patients with SCAC, and no significant difference in outcomes was noted relative to HIV− patients.
Surgical resection is the standard-of-care approach for early-stage non-small cell lung cancer (NSCLC). Surgery is also considered an acceptable standard infit patients with oligometastatic lesions in the lungs. The COVID-19 pandemic has led to worldwide issues with access to operating room time, with patients and physicians facing uncertainty as to when surgical resection will be available, with likely delays of months. Further compounding this are concerns about increased risks of respiratory complications with lung cancer surgery during active phases of the pandemic. In this setting, many thoracic oncology teams are emb...
Purpose/Objective(s): The current study reports long-term overall survival (OS) and biochemical freedom from recurrence (BFFR) after stereotactic body radiation therapy (SBRT) for men with intermediate and high-risk prostate cancer in a single community hospital setting with early adoption.Materials/Methods: Ninety-seven consecutive men with intermediate and high-risk prostate cancer treated with SBRT between 2007 and 2015 were retrospectively studied. Categorical variables for analysis included National Comprehensive Cancer Network risk group, race, Gleason grade group, T stage, use of androgen deprivation therapy, and pl...
Condition: Breast Cancer Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions); Drug: Letrozole 2.5Mg Tab; Drug: Palbociclib 125mg Sponsor: Weill Medical College of Cornell University Not yet recruiting
Publication date: Available online 22 September 2020Source: European UrologyAuthor(s): Liselotte Boevé, Maarten C.C.M. Hulshof, Paul C.M.S. Verhagen, Jos W.R. Twisk, Wim P.J. Witjes, Peter de Vries, R. Jeroen A. van Moorselaar, George van Andel, André N. Vis
The role of radiation therapy in early breast cancer has emerged after two randomized trials that reported there was no significant difference in survival between total mastectomy and breast conserving surgery plus radiation therapy [1,2]. There was a significant decrease of the local recurrence rate in the ipsilateral breast after lumpectomy plus breast irradiation, as compared to lumpectomy alone . In a prospective study in Europe (EORTC 22881-10882), postoperative whole breast irradiation with tumor bed boost significantly improved the 10-year local recurrence rate compared to whole breast irradiation alone in early breast cancer .
CONCLUSIONS: No difference in efficiency or toxicity was shown after SBRT of peripheral NSCLC treatment using Linac or Cyberknife®. ADVANCES IN KNOWLEDGE: This is the first large prospective non-randomized study focusing on peripheral localized NSCLC comparing SBRT using an appropriately equipped linac with Cyberknife®. No significant difference in efficiency or toxicity was shown in this situation. PMID: 32970478 [PubMed - as supplied by publisher]
ConclusionCystus ® and sage tea have a similar effect on the occurrence of radiation-induced mucositis regarding latency and incidence. Cystus® tea mouthwash solution is tolerated well and can be applied in addition to intensive oral care and hygiene along with the application of fluorides.